Skip to content

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit. Comparative of Cost-Effectiveness and Safety

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03908866
Acronym
PICINI
Enrollment
200
Registered
2019-04-09
Start date
2019-04-01
Completion date
2019-12-31
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Economic Problems, Infection, Thromboses, Venous

Brief summary

This study aim to compare the cost-effectiveness and safety between centrally and peripherally inserted central venous catheters in neurosurgical intensive care unit patients.

Interventions

OTHERCVC(Central venous catheter )

The central venous catheter with different sizes (French scale). Trained doctors will perform the insertion of the CVC, using the Seldinger technique. A suitable sterile field will be established.

OTHERPICC(Peripherally inserted central catheter)

The peripherally inserted central catheter with different sizes (French scale). Trained vascular access nurses will perform the insertion of the PICC, guided by ultrasound at bedside using the Seldinger technique. A suitable sterile field will be established.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients admitted to the neurosurgical intensive care unit , who require central access for the treatment of their illness.

Exclusion criteria

* Insertion of the central catheter in emergency situations; * Anatomical abnormalities of upper extremity affecting PICC placement; * Current or recent (within 1 month) diagnosis of bacteremia * Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis; * Presence of skin changes in the area of the puncture, such as thrombophlebitis, dermatitis, cellulitis, burn among others;

Design outcomes

Primary

MeasureTime frameDescription
thrombotic complicationsup to 30 days or be discharged from hospitalradiographically-confirmed upper-extremity deep vein thrombosis
mechanical complicationsup to 30 days or be discharged from hospitalpneumothorax or hematoma caused by puncture
infectious complicationsup to 30 days or be discharged from hospitalcatheter related bloodstream infection

Secondary

MeasureTime frameDescription
catheter replacementup to 30 days or be discharged from hospitalobstruction or accidental removal
cost effectivenessup to 30 days or be discharged from hospitalThe cost of catheter implantation and replacement, as well as the cost of treatment due to catheter-related complications and the resulting financial loss to the patient.

Countries

China

Contacts

Primary ContactHao Liu, MD
hao_liu@xjtu.edu.cn0086-029-85324005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026